查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1529646

切片檢查引導系統市場規模、佔有率、趨勢分析報告：按產品、應用、最終用途、地區和細分市場預測，2024-2030 年

Biopsy Guidance Systems Market Size, Share & Trends Analysis Report By Product (Stereotactic Guided Biopsy, Ultrasound Guided Biopsy, MRI Guided Biopsy), By Application, By End Use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

切片檢查引導系統市場成長與趨勢：

Grand View Research, Inc. 的最新報告顯示，到 2030 年，全球切片檢查引導系統市場規模預計將達到 15.8 億美元。

預計2024年至2030年該市場將以6.1%的複合年成長率成長。癌症盛行率的增加、老年人口的增加、對非侵入性手術的需求增加、技術創新、政府措施的增加以及 COVID-19 的影響是市場的主要促進因素。

切片檢查是診斷癌症和其他慢性疾病的最重要的方法之一，通常用於診斷乳腺癌、腦癌、皮膚癌和前列腺癌。癌症盛行率的增加是市場成長的主要驅動力。例如，根據 Cancer.org 的數據，預計 2021 年美國將有約 190 萬人新診斷出罹患癌症。由於切片檢查引導系統是癌症早期診斷所需的關鍵要求之一，預計癌症病例數量的增加將在預測期內推動市場成長。

此外，市場也越來越偏好微創切片檢查治療。預計多種類型的技術和產品將在預測期內迅速擴展，例如機器人輔助切片檢查引導系統、針活體組織切片槍和真空輔助核心切片檢查系統。例如，2021 年 3 月，IZI Medical Products, LLC 推出了用於軟組織切片檢查的 Quick-Core 自動活體組織切片系統。這是一款輕型全自動切片檢查設備，具有可靠性、品質和準確性。此外，人們對乳癌治療和診斷的認知不斷提高，預計將在預測期內進一步推動市場成長。

切片檢查引導系統市場報告亮點

  • 立體定位切片檢查佔據市場主導地位，2023年佔39.9%的佔有率。
  • 2023年，腦切片檢查領域佔據最大的市場收益佔有率。腦部切片檢查被認為是診斷無法手術切除的腦腫瘤最可靠的方法。
  • 康復中心細分市場在行業中佔據主導地位，並在 2023 年佔據最大的收益佔有率。這可能是由於診所擴大採用切片檢查指導框架。
  • 北美切片檢查引導系統市場在 2023 年以 45.4% 的收益佔有率佔據市場主導地位。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章切片檢查引導系統市場變數、趨勢、範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 切片檢查引導系統市場分析工具
    • 波特的分析
    • PESTEL分析

第4章切片檢查引導系統市場：依產品估計和趨勢分析

  • 細分儀表板
  • 切片檢查引導系統市場：2023 年和 2030 年按產品分類的變異分析
  • 立體定位切片檢查
  • 超音波引導切片檢查
  • MRI導引切片檢查

第5章切片檢查引導系統市場：按應用估計和趨勢分析

  • 細分儀表板
  • 切片檢查引導系統市場：2023 年和 2030 年按應用分類的變化分析
  • 腦部切片檢查
  • 乳房切片
  • 其他

第6章切片檢查引導系統市場：最終用途的估計和趨勢分析

  • 細分儀表板
  • 切片檢查引導系統市場：2023 年和 2030 年最終用途的變化分析
  • 醫院
  • 專科診所
  • 診斷中心
  • 研究/學術機構

第7章切片檢查引導系統市場：區域估計和趨勢分析

  • 2023 年和 2030 年切片檢查引導系統市場佔有率（按地區）
  • 北美洲
    • 2018-2030 年北美切片檢查引導系統市場估計與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2018-2030年歐洲切片檢查引導系統市場估計與預測
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018-2030 年亞太地區切片檢查引導系統市場估計與預測
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 2018-2030 年拉丁美洲切片檢查引導系統市場估計與預測
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 中東和非洲切片檢查引導系統市場估計和預測，2018-2030 年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 科威特

第8章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Becton, Dickinson, and Company
    • Hologic, Inc.
    • Devicor Medical Products, Inc.
    • B. Braun Melsungen AG
    • ARGON MEDICAL
    • Boston Scientific Corporation
    • INRAD Inc.
    • Cook Medical
    • PLANMED OY
簡介目錄
Product Code: GVR-4-68039-395-9

Biopsy Guidance Systems Market Growth & Trends:

The global biopsy guidance systems market size is expected to reach USD 1.58 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 6.1% from 2024 to 2030. The increasing prevalence of cancer, rise in the geriatric population, growing demand for non-invasive procedures, technological innovations, a rising number of government initiatives, and impact of COVID-19 are the key driving factors for the market.

A biopsy is one of the most prominent procedures for diagnosing cancer amongst other chronic diseases, and it is commonly employed in the diagnosis of breast, brain, skin, and prostate cancer. The increasing prevalence of cancer is a major factor responsible for market growth. For instance, according to Cancer.org, in 2021, around 1.9 million new cancer cases are expected to be diagnosed in the US. Since the biopsy guidance system is one of the major requirements for the initial diagnosis of cancer, thus, rising number of cancer cases is anticipated to propel market growth over the forecast period

Furthermore, there is a rising preference for minimally invasive biopsy treatments in the market. During the forecast period, several types of technologies and products including robot-assisted biopsy guidance systems, needle-based biopsy guns, and vacuum-assisted core biopsy systems, are expected to expand rapidly. For instance, in March 2021, IZI Medical Products, LLC launched Quick-Core Auto Biopsy System for soft tissue biopsy. It is a lightweight, completely automatic biopsy device and provides reliability, quality, and accuracy. Additionally, rising awareness of breast cancer treatment and diagnosis will further boost market growth over the forecast period.

Biopsy Guidance Systems Market Report Highlights:

  • The stereotactic guided biopsy dominated the market and accounted for a share of 39.9% in 2023
  • The brain biopsy section accounted for the largest market revenue share in 2023. Brain biopsy is considered the most reliable method to diagnose brain tumors that cannot be surgically removed.
  • The healing centers segment dominated the industry and held the largest revenue share in 2023. It can be attributed to increased adoption of biopsy direction frameworks in clinics.
  • North America biopsy guidance system market dominated the market and accounted for revenue share of 45.4% in 2023.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Biopsy Guidance Systems Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Biopsy Guidance Systems Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Biopsy Guidance Systems Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Biopsy Guidance Systems Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Stereotactic Guided Biopsy
    • 4.3.1. Stereotactic Guided Biopsy Guidance Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Ultrasound Guided Biopsy
    • 4.4.1. Ultrasound Guided Biopsy Guidance Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. MRI Guided Biopsy
    • 4.5.1. MRI Guided Biopsy Guidance Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Biopsy Guidance Systems Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Biopsy Guidance Systems Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Brain Biopsy
    • 5.3.1. Brain Biopsy Guidance Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Breast Biopsy
    • 5.4.1. Breast Biopsy Guidance Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Biopsy Guidance Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Biopsy Guidance Systems Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Biopsy Guidance Systems Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Hospitals
    • 6.3.1. Biopsy Guidance Systems In Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Specialty Clinics
    • 6.4.1. Biopsy Guidance Systems In Specialty Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Diagnostic Centers
    • 6.5.1. Biopsy Guidance Systems In Diagnostic Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Research and Academic Institutes
    • 6.6.1. Biopsy Guidance Systems for Research and Academic Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Biopsy Guidance Systems Market: Regional Estimates & Trend Analysis

  • 7.1. Biopsy Guidance Systems Market Share, By Region, 2023 & 2030 (USD Billion)
  • 7.2. North America
    • 7.2.1. North America Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. France Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Italy Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Spain Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Norway Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. China
      • 7.4.2.1. China Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Japan Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Australia Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Australia Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Brazil Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Saudi Arabia
      • 7.6.2.1. Saudi Arabia Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. UAE
      • 7.6.3.1. UAE Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. South Africa
      • 7.6.4.1. South Africa Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. South Africa Biopsy Guidance Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Becton, Dickinson, and Company
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. Hologic, Inc.
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. Devicor Medical Products, Inc.
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. B. Braun Melsungen AG
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. ARGON MEDICAL
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. Boston Scientific Corporation
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. INRAD Inc.
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. Cook Medical
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. PLANMED OY
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives